Renaissance BioScience and the Vaccine and Infectious Disease Organization address the porcine epidemic diarrheal virus and porcine reproductive and respiratory syndrome virus.
Renaissance BioScience has strategically partnered with the Vaccine and Infectious Disease Organization. This collaboration was awarded $600,000 by the Saskatchewan Agricultural Development Fund and will target two diseases, as well as immune system function, in pigs and piglets using Renaissance’s yeast-based technology. Dr. Heather Wilson will coordinate the two distinct projects at VIDO. Wilson is a prominent scientist and program leader in vaccine formulation and delivery and was chosen as one of the most Influential Women in Canadian Agriculture in 2023.
In one project, RBSC and VIDO will pioneer orally delivered yeast-based vaccines for porcine epidemic diarrheal virus and porcine reproductive and respiratory syndrome virus. These diseases pose significant threats to the global swine industry, leading to multi-billion-dollar losses annually.